CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 171, Issue 1, 1999, Pages 49-55

  Fukazawa, Toshiyuki ^a   Yanagawa, Tatsuo ^b   Kikuchi, Seiji ^c   Yabe, Ichiro ^c   Sasaki, Hidenao ^c   Hamada, Takeshi ^a   Miyasaka, Kazuo ^c   Gomi, Kiyohide ^b   Tashiro, Kunio ^c  

^a Hokuyukai Neurology Hospital   (Japan)

^b Nerima General Hospital   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CTLA 4; Japan; Multiple sclerosis; Oligoclonal IgG bands; Prognosis

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BRAIN; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULINS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX;

EID: 0032719489     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00251-8     Document Type: Article

References (46)

1. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-197.
2. Steinman L. A coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
3. Tiwari J.L., Terasaki P.I. Multiple sclerosis. Tiwari J.L., Terasaki P.I. HLA and disease associations. 1985;152-167 Springer-Verlag, New York.
4. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann. Neurol. 36:1994;S15-S17.
5. Compston D.A.S., Kellar Wood H., Robertson N., Sawcer S., Wood N.W. Genes and susceptibility to multiple sclerosis. Acta Neurol. Scand. Suppl 161:1995;43-51.
6. Batchelor J.R., Compston A., McDonald W.I. The significance of the association between HLA and multiple sclerosis. Brit. Med. Bull. 34:1978;279-284.
7. Sawcer S., Jones H.B., Feakes R., et al. A genome screen in multiple sclerosis redeals susceptibility loci on chromosomes 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
8. Haines J.L., Ter-Minassian M., Bazyk A., et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
9. Ebers G.C., Kukay K., Bulmann D.E., et al. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
10. Waterhouse P., Penninger J.M., Timms F., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:1996;985-988.
11. Chambers C.A., Krummel M.F., Boitel B., et al. The role of CTLA-4 in the regulation of T-cell responses. Immunol. Rev. 153:1996;27-46.
12. Walunas T.L., Lenshow D.J., Bakker C.Y., et al. CTLA-4 can function as a negative regulator of T-cell activation. Immunity. 1:1994;405-413.
13. Lee K.M., Chuang E., Griffin M., et al. Molecular basis of T-cell inactivation by CTLA-4. Science. 282:(5397):1998;2263-2266.
14. Yanagawa T., Hidaka Y., Guimaraes V., Soliman M., DeGroot L.J. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80:1995;41-45.
15. Yanagawa T., Taniyama M., Enomoto S., Gomi K., Maruyama H., Ban Y., Saruta T. CTLA-4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid. 7:1997;843-846.
16. Kotsa K., Watson P.F., Weetman A.P. A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin. Endocrinol. 46:1997;551-554.
17. Donner H., Rau H., Walfish P.G., et al. CTLA4 alanin-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes melitus. J. Clin. Endocrinol. Metab. 82:1997;143-146.
18. Donner H., Braun J., Seidl C., et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82:1997;4130-4132.
19. Nistico L., Buzetti R., Pritchard L.E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, thpe 1 diabetes. Hum. Mol. Genet. 5:1996;1075-1080.
20. Marron M.P., Raffel L.J., Garchon H.-J., et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphism in multiple ethnic groups. Hum. Mol. Genet. 6:1997;1275-1282.
21. Awata T., Kurihara S., Iitaka M., et al. Association of CTLA-4 gene A/G polymorphism (IDDM2 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves's disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes. 47:1998;128-129.
22. Vav Der Auwera B.J., Vandewalle C.L., Schuit F.C., et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin. Exp. Immunol. 110:1997;98-103.
23. Seidl C., Donner H., Fischer B., Usadel K.-H., Seifried E., Kaltwasser J.P., Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens. 51:1998;62-66.
24. Huang D., Liu L., Noren K., Xia S., Trifunovic J., Pitvia R., Lefvert A.K. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J. Neuroimmunol. 88:1998;192-198.
25. Harbo H.F., Celius E.G., Vartdal F., Spurkland A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens. 53:1999;106-110.
26. Fukazawa T., Hamada T., Tashiro K., Moriwaka F., Yanagihara T. Acute transverse myelopathy in multiple sclerosis. J. Neurol. Sci. 100:1990;217-222.
27. Fukazawa T., Miyasaka K., Tashiro K., et al. MRI findings of multiple sclerosis with acute transverse myelopathy. J. Neurol. Sci. 110:1992;27-31.
28. Fukazawa T., Hamada T., Moriwaka F., Tashiro K. Acute transverse myelopathy in MS: clinical considerations. Intern. MS J. 1:1994;26-33.
29. Fukazawa T., Hamada T., Tashiro K., et al. HLA profiles of multiple sclerosis in Hokkaido, the northernmost island of Japan. Acta Neurol. Scand. 86:1992;517-520.
30. Kira J., Kanai T., Nishimuta Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann. Neurol. 40:1996;569-574.
31. Fukazawa T., Kikuchi S., Sasaki H., et al. Anti-nuclear antibodies and the optic spinal form of multiple sclerosis. J. Neurol. 244:1997;483-488.
32. Fukazawa T., Moriwaka F., Mukai M., Hamada T., Koike T., Tashiro K. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol. Scand. 88:1993;184-189.
33. Fukazawa T., Hamada T., Kikuchi S., Sasaki H., Tashiro K. Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan. J. Neurol. Neurosurg. Psychiatry. 61:1996;203-204.
34. Poser C.M., Paty D.W., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
35. Fukazawa T., Tashiro K., Hamada T., et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern. Med. 31:1992;349-352.
36. Buyse I., Decorte R., Baens M., et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens. 41:1993;1-14.
37. Fukazawa T., Kikuchi S., Sasaki H., Hamada K., Hamada T., Miyasaka K., Tashiro K. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic background. J. Neurol. Sci. 158:1998;209-214.
38. Weinshenker B.G., Bulman D., Carriere W., Baskerville J., Ebers G.C. A comparison of sporadic and familial multiple sclerosis. Neurology. 40:1990;1354-1358.
39. Runmarker B., Martinssen T., Wahlstrom J., Anderson O. HLA and prognosis in multiple sclerosis. J. Neurol. 241:1994;385-390.
40. Ebers G.C., Sadovnick A.D. The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54:1994;1-17.
41. Weyand C.M., Hicok K.C., Conn D.L., Goronzy J.J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann. Intern. Med. 117:1992;801-806.
42. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:1995;179-200.
43. Stendahl-Brodin L., Link H. Relation between benighn course of multiple sclerosis and low-grade humoral immune response in cerebral spinal fluid. J. Neurol. Neurosurg. Psychiatry. 43:1980;102-105.
44. Zehman A.Z.J., Kidd D., McLean B.N., et al. A study of oligoclonal band negative multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 60:1996;27-30.
45. Pender M.P. Genetically determined failure of activation-induced apoptosis of autoreactive T-cells as a cause of multiple sclerosis. Lancet. 351:1998;978-981.
46. Dowling P., Huser W., Mennona J., et al. Cell death and birth in multiple sclerosis. J. Neurol. Sci. 149:1997;1-11.